Interestingly, groups treated with miRNA-34a/Tat-E60 or miRNA-34a/A86 displayed the slowest tumor spheroid growth rates in a dose-dependent manner, leading to a subsequent reduction in tumor size on day 10 post-treatment. This evidence concerns the gene TAT and neoplasm.